Meningitis

doi:10.1017/CBO9780511543579.199

Meningitis

from Medical topics

Published online by Cambridge University Press: 18 December 2014

Edited by

John Weinman and

Julie A. Carter: Affiliation:
University College London and Kenya Medical Research Institute/Wellcome Trust Research Laboratories
Susan Ayers: Affiliation:
University of Sussex
Andrew Baum: Affiliation:
University of Pittsburgh
Chris McManus: Affiliation:
St Mary's Hospital Medical School
Stanton Newman: Affiliation:
University College and Middlesex School of Medicine
Kenneth Wallston: Affiliation:
Vanderbilt University School of Nursing
John Weinman: Affiliation:
United Medical and Dental Schools of Guy's and St Thomas's
Robert West: Affiliation:
St George's Hospital Medical School, University of London

Book contents

Get access

Summary

Meningitis is an acute infectious disease, arising from infection of the membranes surrounding the brain and spinal cord by one of several microorganisms, such as bacteria, viruses, parasites and fungi. Recovery from meningitis has long been associated with severe neurological and/or cognitive deficits, including hearing impairment, epilepsy, motor impairments and learning disability. Those surviving without obvious or severe deficits have traditionally been considered to make a complete recovery. This view has recently been challenged by evidence that subtle cognitive, academic or behavioural problems may persist years after recovery from the disease.

Overview

Most research studies on impairments associated with meningitis have examined bacterial meningitis. Acute bacterial meningitis is one of the most common infections of the central nervous system (CNS). In more developed countries, Streptococcus pneumoniae and Neisseria meningitides are the most common pathogens responsible for community-acquired bacterial meningitis. Haemophilus influenzae meningitis has almost been eliminated due to the Hib vaccination. Bacterial meningitis is 10 times more common in children from less developed than more developed countries and the case fatality rate is higher, partly due to the prevalence of HIV infection, which makes children more prone to invasive bacterial infections (Molyneux et al., 2003). In sub-Saharan Africa, the ‘meningitis belt’, an area stretching from Senegal in the west to Ethiopia in the east with a population of 300 million people, is also subject to recurring epidemics of meningococcal disease, primarily due to the serogroups N. meningitidis A, C and W135.

Type: Chapter
Information: Cambridge Handbook of Psychology, Health and Medicine , pp. 776 - 779

DOI: https://doi.org/10.1017/CBO9780511543579.199 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baraff, L. J., Lee, S. I. & Schriger, D. L. (1993). Outcomes of bacterial meningitis in children: a meta-analysis. Pediatric Infectious Disease Journal, 12, 389–94.Google Scholar

Carter, J. A., Neville, B. G. R. & Newton, C. R. J. C. (2003). Neuro-cognitive sequelae of acquired central nervous system infections in children: a systematic review. Brain Research Reviews, 43, 57–69.Google Scholar

Day, J. N. & Lalloo, D. G. (2004). Neurological syndromes and the traveler: an approach to differential diagnosis. Journal of Neurology Neurosurgery and Psychiatry, 75 (suppl. 1), i2–9.Google Scholar

Donald, P. R. & Schoeman, J. F. (2004). Tuberculous meningitis. New England Journal of Medicine, 351, 1719–20.Google Scholar

Franco, S. M., Cornelius, V. E. & Andrews, B. F. (1992). Long-term outcome of neonatal meningitis. American Journal of Diseases of Children, 146, 567–71.Google Scholar

Grimwood, K., Anderson, V. A., Bond, L.et al. (1995). Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics, 95, 646–56.Google Scholar

Klinger, G., Chin, C. N., Beyene, J. & Perlman, M. (2000). Predicting the outcome of neonatal bacterial meningitis. Pediatrics, 106, 477–82.Google Scholar

Koomen, I., Grobbee, D. E., Jennekens-Schinkel, A., Roord, J. J. & Furth, A. M. (2003). Parental perception of educational, behavioural and general health problems in school-age survivors of bacterial meningitis. Acta Paediatrica, 92, 177–85.Google Scholar

Koomen, I., Grobbee, D. E., Roord, J. J.et al. (2004 b). Prediction of academic and behavioural limitations in school-age survivors of bacterial meningitis. Acta Paediatrica, 93, 1378–85.Google Scholar

Koomen, I., Furth, A. M., Kraak, M. A. C.et al. (2004 a). Neuropsychology of academic and behavioural limitations in school-age survivors of bacterial meningitis. Developmental Medicine and Child Neurology, 46, 724–32.Google Scholar

McIntyre, P. B., Berkey, C. S., King, S. M.et al. (1997). Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. Journal of the American Medical Association, 278, 925–31.Google Scholar

Molyneux, E. M., Tembo, M., Kayira, K.et al. (2003). The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. Archives of Disease in Childhood, 88, 1112–18.Google Scholar

Pikis, A., Kavaliotis, J., Tsikoulas, J.et al. (1996). Long-term sequelae of pneumococcal meningitis in children. Clinical Pediatrics, 35, 72–8.Google Scholar

Pomeroy, S. L., Holmes, S. J., Dodge, P. R. & Feigin, R. D. (1990). Seizures and other neurologic sequelae of bacterial meningitis in children. New England Journal of Medicine, 323, 1651–7.Google Scholar

Richardson, M. P., Reid, A., Tarlow, M. J. & Rudd, P. T. (1997). Hearing loss during bacterial meningitis. Archives of Disease in Childhood, 76, 134–8.Google Scholar

Saez-Llorens, X. & McCracken, G. H. Jr. (2003). Bacterial meningitis in children. Lancet, 361, 2139–48.Google Scholar

Salih, M. A., Khaleefa, O. H., Bushara, M.et al. (1991). Long term sequelae of childhood acute bacterial meningitis in a developing country. A study from the Sudan. Scandinavian Journal of Infectious Diseases, 23, 175–82.Google Scholar

Thwaites, G. E., Nguyen, D. B., Nguyen, H. D.et al. (2004). Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New England Journal of Medicine, 351, 1741–51.Google Scholar

Beek, D., Gans, J., McIntyre, P. & Prasad, K. (2004 b). Steroids in adults with bacterial meningitis: a systematic review. Lancet Infectious Diseases, 3, 139–43.Google Scholar

Beek, D., Gans, J., Spanjaard, L.et al. (2004 a). Clinical features and prognostic factors in adults with bacterial meningitis. New England Journal of Medicine, 351, 1849–59.Google Scholar

Book contents

Meningitis

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive